The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

It appears that patients experience some weight loss even after they stop taking the drug ... while still having plenty left over to invest in its other research and development (R&D) programs. It ...

A systematic review of randomized controlled trials (RCTs) found that weight-loss interventions were associated with improvements in some polycystic ovary syndrome (PCOS) symptoms, including ...

Medications like Ozempic and Wegovy are famous for their weight loss benefits, but some scientists want to know more about how these drugs impact muscle loss. In a new commentary for The Lancet, an ...

Ozempic is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help with blood sugar control ...

Axios Visuals Budget pressures have kept all but 13 states from covering GLP-1 drugs for weight loss through their Medicaid programs, a new report from KFF shows. Why it matters: The restrictive ...

The two major party candidates provide ample reasons for pessimism about the future of the republic. If you're a fanatical ...

By deflecting from their anti-competitive practices, drug companies can charge whatever price they want on their products.

Survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals; respondents want to lose an ...

What: Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss and resolution of common obesity-related comorbidities 10 years ...

The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.